Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/26/24 | $372,000,000 | Series D |
Andreessen Horowitz Emerson Collective FPV Ventures Lachy Groom Sanofi Sequoia Capital SV Angel Thrive Capital | undisclosed |
